Goldstein David M sold $68K of ALMS
Goldstein David M (Chief Scientific Officer) sold 2,596 shares of ALUMIS INC. (ALMS) at $26.37 on 2026-08-03.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market sale size, price, and post-transaction holdings by the Chief Scientific Officer.
Market read
Traders may note insider selling, but there is no accompanying guidance, contract, or regulatory development in the text.
What to watch
The filing does not state a 10b5-1 plan, but it also provides no reason for the sale, so interpreting it as information is speculative.
Background
The article is a SEC Form 4 insider transaction disclosure for ALUMIS INC. (ALMS).
Ticker impact
ALMS disclosed a Form 4 showing Chief Scientific Officer David M Goldstein sold 2,596 shares at $26.37 on 2026-08-03.
Likely limited near-term impact; any effect would be sentiment-only and typically fades unless paired with other disclosures.
Form 4 insider sales are common and often non-informational; the filing provides transaction details but no company-specific operational or financial change.
Market effects
No sector-level signal; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
The sale may be routine liquidity management and not a bearish signal, especially since insider sales frequently occur without any subsequent negative company news.
Key entities
- issuerALUMIS INC.
Company subject of the Form 4 insider transaction disclosure.
- insiderDavid M Goldstein
Chief Scientific Officer who sold 2,596 shares.
